Sterilization Education

A Better Game Plan for Sterilization Validation

We submit that there’s a smoother, faster way to structure and execute E-Beam sterilization validations.

How did we get here?
Traditionally, Gamma dominated the radiation sterilization market (90%+ of products were done in gamma). A typical gamma sterilization process flow is laid out below:

This approach makes a lot of sense for gamma, where penetration and depth-dose performance is excellent. But, with Cobalt-60 supply constraints and years of attendant price increases, device OEMs are looking for more sustainable and economical approaches to sterilization: E-Beam delivers these benefits. But while E-Beam is a superior technology from a sustainability and pricing perspective, it is disadvantaged in depth-dose penetration performance versus Gamma.

Addressing the Elephant in the Room, First

Given that we know the depth-dose performance of E-Beam is limited, it makes sense to address this early on in the validation process. There are two paths available to rapidly evaluate what dose range that a product will experience:

  1. Virtual dose mapping (VDM) tools – we have written before on the use of these advanced computational tools for running Monte Carlo simulations that project dose. We love VDM as a technology because it can help OEMs understand dose distribution very early on in the development process – before even prototype product is manufactured.
  2. Early physical dose mapping – the ISO 11137 standard for radiation sterilization still requires a physical dose map. But moving this forward in the process makes great sense for several reasons:
    1. Dose mapping is typically inexpensive (~$2,500 for a triplicate map) and quick (done in a few weeks, with faster turnaround times available).
    2. Dose mapping early provides a clear target for what maximum permissible dose should be, helping to clarify the maximum permissible testing process.

So, we think the sequence for a more efficient sterilization validation approach for E-Beam should look something like this:

The optimized (blue) pathway highlights the delays from the legacy (red). We think that this modification can help customers better understand how E-Beam will work with their product early, enabling them to run a more efficient and effective sterilization validation process.

NextBeam Is Here to Help

As always, please reach out to us at NextBeam for a free consultation with a sterilization expert – we’re happy to help. Contact us today to get started.

Additional Articles We Think You Might Like

Have a question? Speak with a sterilization expert today, at your own convenience.

FDA Food & Beverage Recall Volume Is Rising. Are Your Kill Steps Enough?

What Drove the 2025 FDA Recalls New FDA and FSIS data demonstrate that food & beverage-based recalls hit an all-time high in 2025. Some data points we find the most interesting (from Food Safety...

FDA Data Reveals that 63% of Pet Food Recalls Are Preventable

This article is a excerpt from our white paper that contains the full findings. Download the white paper. New analysis from NextBeam shows that 63% of pet food and treat recalls stem from issues that...

Q3 2025 | NextBeam Sterilization Market Update

At NextBeam, we closely follow the North American sterilization market. Our goal is to track changes in technology, regulation, and pricing so we can share relevant insights with customers, partners...